Lung Cancer Rx

Neoadjuvant Therapy for Early-Stage Lung Cancer: Where Do Things Stand, and What’s Next?

29 min · 1. maj 2026
episode Neoadjuvant Therapy for Early-Stage Lung Cancer: Where Do Things Stand, and What’s Next? cover

Beskrivelse

Given recent advances, where do things stand for neoadjuvant therapy in patients with NSCLC? The panel discusses current considerations and what important questions may soon be answered. Patrick Forde MBBCh, PhD, a thoracic medical oncologist at Johns Hopkins University in Baltimore, Maryland, and professor of immuno-oncology at Trinity College Dublin discusses current multidisciplinary approaches to perioperative care in NSCLC with Eric K. Singhi, MD, a thoracic oncologist in Houston, and Aakash Desai, MD, MPH, an assistant professor at the University of Alabama at Birmingham’s O’Neal Cancer Center.

Kommentarer

0

Vær den første til at kommentere

Tilmeld dig nu og bliv en del af Lung Cancer Rx-fællesskabet!

Kom i gang

1 måned kun 9 kr.

Derefter 99 kr. / måned · Opsig når som helst.

  • Podcasts kun på Podimo
  • 20 lydbogstimer pr. måned
  • Gratis podcasts

Alle episoder

12 episoder